**Core Concept**
Clozapine is an atypical antipsychotic medication, primarily used for the treatment of schizophrenia, particularly in patients who are resistant to other antipsychotics. Its unique pharmacological profile makes it a valuable option for patients with treatment-resistant schizophrenia.

**Why the Correct Answer is Right**
Clozapine's efficacy in treatment-resistant schizophrenia is attributed to its ability to modulate multiple neurotransmitter systems, including dopamine, serotonin, and norepinephrine. This polypharmacology allows Clozapine to target multiple receptors, including D2, D3, and 5-HT2A, which are often involved in the pathophysiology of schizophrenia. Additionally, Clozapine's low affinity for dopamine D2 receptors in the nigrostriatal pathway reduces the risk of extrapyramidal side effects.

**Why Each Wrong Option is Incorrect**
**Option A:** Clozapine is not primarily used for the treatment of bipolar disorder. While it may be used as an adjunctive therapy, its primary indication is for treatment-resistant schizophrenia.
**Option B:** Clozapine is not typically used as a first-line treatment for schizophrenia. Its use is usually reserved for patients who have failed to respond to other antipsychotics.
**Option C:** Clozapine is not used for the treatment of acute psychosis. Its use is generally limited to patients with chronic or treatment-resistant schizophrenia.

**Clinical Pearl / High-Yield Fact**
It is essential to monitor patients on Clozapine for agranulocytosis, a potentially life-threatening decrease in white blood cell count. Regular blood tests are necessary to detect this condition early.

**Correct Answer: C. Treatment-resistant schizophrenia.